ACOR - Acorda sees 2019 total revenue as high as 188M January, 15 2020 07:14 AM Acorda Therapeutics Inc. Acorda Therapeutics (NASDAQ:ACOR) provides 2019 highlights 2020 guidance at the Annual JPM Conference in San Francisco.More news on: Acorda Therapeutics, Inc., Healthcare stocks news, , Read more ...